17
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Comparative Receptor Surface Analysis (CoRSA) Model for Calcium Channel Antagonists

, &
Pages 93-111 | Received 14 Jul 2000, Accepted 15 Sep 2000, Published online: 27 Oct 2006
 

Abstract

Three-dimensional quantitative structure-activity relationships (3D QSAR) are widely used for the prediction of in vitro or in vivo interactions between chemical compounds and their biological targets (transporters, receptors, ion channels, enzymes). Comparative receptor surface analysis (CoRSA) is a new 3D QSAR algorithm that can be applied to study ligand-receptor interactions whenever the structure of the biological target is not known. The steric and electrostatic features of the most active compounds from a QSAR set are used by CoRSA to generate a virtual receptor model, represented as points on a surface complementary to the van der Waals surface of the aligned compounds. The CoRSA structural descriptors, represented by the total interaction energies between each surface point of the virtual receptor and all atoms in a molecule, are used in a partial least squares data analysis to generate a structure-activity model. In this paper the calcium channel antagonist activity of 35 dihydropyridine derivatives is modeled with CoRSA, giving a 3D QSAR with r 2=0.928 for calibration and r cv 2 = 0.921 for the leave-one-out cross-validation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.